These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 30697805)

  • 1. The evolving risk of sudden cardiac death after heart transplant. An analysis of the ISHLT Thoracic Transplant Registry.
    Alba AC; Fan CS; Manlhiot C; Dipchand AI; Stehlik J; Ross HJ
    Clin Transplant; 2019 Mar; 33(3):e13490. PubMed ID: 30697805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence and predictors of sudden cardiac death after heart transplantation: A systematic review and meta-analysis.
    Alba AC; Foroutan F; Ng Fat Hing NKV; Fan CS; Manlhiot C; Ross HJ
    Clin Transplant; 2018 Mar; 32(3):e13206. PubMed ID: 29349819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence, predictors, and temporal trends of sudden cardiac death after heart transplantation.
    Vakil K; Taimeh Z; Sharma A; Abidi KS; Colvin M; Luepker R; Levy WC; Adabag S
    Heart Rhythm; 2014 Oct; 11(10):1684-90. PubMed ID: 25048441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of pre-heart transplant body mass index on posttransplant outcomes: An analysis of the ISHLT Registry Data.
    Doumouras BS; Fan CS; Mueller B; Dipchand AI; Manlhiot C; Stehlik J; Ross HJ; Alba AC
    Clin Transplant; 2019 Jul; 33(7):e13621. PubMed ID: 31152559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction model for cardiac allograft vasculopathy: Comparison of three multivariable methods.
    Kransdorf EP; Loghmanpour NA; Kanwar MK; Temkit MH; Stehlik J
    Clin Transplant; 2017 Apr; 31(4):. PubMed ID: 28181298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statin therapy is not associated with improved outcomes after heart transplantation in children and adolescents.
    Greenway SC; Butts R; Naftel DC; Pruitt E; Kirklin JK; Larsen I; Urschel S; Knecht K; Law Y
    J Heart Lung Transplant; 2016 Apr; 35(4):457-65. PubMed ID: 26746989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term outcome of cardiac allograft vasculopathy: Importance of the International Society for Heart and Lung Transplantation angiographic grading scale.
    Van Keer JM; Van Aelst LNL; Rega F; Droogne W; Voros G; Meyns B; Vanhaecke J; Emonds MP; Janssens S; Naesens M; Van Cleemput J
    J Heart Lung Transplant; 2019 Nov; 38(11):1189-1196. PubMed ID: 31543298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac allograft vasculopathy and graft failure in pediatric heart transplant recipients after rejection with severe hemodynamic compromise.
    Kleinmahon JA; Gralla J; Kirk R; Auerbach SR; Henderson HT; Wallis GA; Ramakrishnan K; Singh RK; Caldwell RL; Savage AJ; Everitt MD
    J Heart Lung Transplant; 2019 Mar; 38(3):277-284. PubMed ID: 30638837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Clinical Rejection Versus Rejection on Protocol Biopsy With Cardiac Allograft Vasculopathy in Pediatric Heart Transplant Recipients.
    Asimacopoulos EP; Garbern JC; Gauvreau K; Blume ED; Daly KP; Singh TP
    Transplantation; 2020 Jan; 104(1):e31-e37. PubMed ID: 31568274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of cardiac allograft vasculopathy incidence between simultaneous multiorgan and isolated heart transplant recipients in the United States.
    Shahandeh N; Kim JS; Klomhaus AM; Tehrani DM; Hsu JJ; Nsair A; Khush KK; Fearon WF; Parikh RV
    J Heart Lung Transplant; 2024 Oct; 43(10):1737-1746. PubMed ID: 38950666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of recipient age and causes of heart transplant mortality: Implications for personalization of post-transplant management-An analysis of the International Society for Heart and Lung Transplantation Registry.
    Wever-Pinzon O; Edwards LB; Taylor DO; Kfoury AG; Drakos SG; Selzman CH; Fang JC; Lund LH; Stehlik J
    J Heart Lung Transplant; 2017 Apr; 36(4):407-417. PubMed ID: 27686602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in Outcomes of Cardiac Allograft Vasculopathy Over 30 Years Following Heart Transplantation.
    Tremblay-Gravel M; Racine N; de Denus S; Ducharme A; Pelletier GB; Giraldeau G; Liszkowski M; Parent MC; Carrier M; Fortier A; White M
    JACC Heart Fail; 2017 Dec; 5(12):891-901. PubMed ID: 29191295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac allograft vasculopathy in pediatric heart transplant recipients does early-onset portend a worse prognosis?
    Khoury M; Conway J; Gossett JG; Edens E; Soto S; Cantor R; Koehl D; Barnes A; Exil V; Glass L; Kirklin JK; Zuckerman WA
    J Heart Lung Transplant; 2022 May; 41(5):578-588. PubMed ID: 35172937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C4d immunostaining is an independent predictor of cardiac allograft vasculopathy and death in heart transplant recipients.
    Luk A; Alba AC; Butany J; Tinckam K; Delgado D; Ross HJ
    Transpl Int; 2015 Jul; 28(7):857-63. PubMed ID: 25778989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Value of the first post-transplant biopsy for predicting long-term cardiac allograft vasculopathy (CAV) and graft failure in heart transplant patients.
    Labarrere CA; Woods JR; Hardin JW; Campana GL; Ortiz MA; Jaeger BR; Baldridge LA; Pitts DE; Kirlin PC
    PLoS One; 2012; 7(4):e36100. PubMed ID: 22558345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retransplant and Medical Therapy for Cardiac Allograft Vasculopathy: International Society for Heart and Lung Transplantation Registry Analysis.
    Goldraich LA; Stehlik J; Kucheryavaya AY; Edwards LB; Ross HJ
    Am J Transplant; 2016 Jan; 16(1):301-9. PubMed ID: 26274617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Routine C4d immunohistochemistry in cardiac allografts: Long-term outcomes.
    Husain AN; Mirza KM; Fedson SE
    J Heart Lung Transplant; 2017 Dec; 36(12):1329-1335. PubMed ID: 28988608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of cytomegalovirus infection in the development of cardiac allograft vasculopathy after heart transplantation.
    Delgado JF; Reyne AG; de Dios S; López-Medrano F; Jurado A; Juan RS; Ruiz-Cano MJ; Dolores Folgueira M; Gómez-Sánchez MÁ; Aguado JM; Lumbreras C
    J Heart Lung Transplant; 2015 Aug; 34(8):1112-9. PubMed ID: 25940077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early aspirin initiation following heart transplantation is associated with reduced risk of allograft vasculopathy during long-term follow-up.
    Peled Y; Lavee J; Raichlin E; Katz M; Arad M; Kassif Y; Peled A; Asher E; Elian D; Har-Zahav Y; Shlomo N; Freimark D; Goldenberg I; Klempfner R
    Clin Transplant; 2017 Dec; 31(12):. PubMed ID: 28990263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk evaluation using gene expression screening to monitor for acute cellular rejection in heart transplant recipients.
    Moayedi Y; Foroutan F; Miller RJH; Fan CS; Posada JGD; Alhussein M; Tremblay-Gravel M; Oro G; Luikart HI; Yee J; Shullo MA; Khush KK; Ross HJ; Teuteberg JJ
    J Heart Lung Transplant; 2019 Jan; 38(1):51-58. PubMed ID: 30352779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.